Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Can fibroblast growth factor 23 fine-tune therapies for diseases of abnormal mineral ion metabolism?

Can fibroblast growth factor 23 fine-tune therapies for diseases of abnormal mineral ion metabolism? Nat Clin Pract Endocrinol Metab. 2007 Dec; 3(12):788-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.